Skip to main content
. 2009 Jul 3;28(1):97. doi: 10.1186/1756-9966-28-97

Table 1.

Immunohistochemical staining for HER 2 according to clinical characteristics of patients, stage and histological type of tumor

Patient characteristics Number of patients HER 2 +(%)
Total Patients 73 21 (28.8)

Sex
Male 69 19 (27.5)
Female 4 2 (50)

Stage
Stage IIIB 30 9 (30)
Stage IV 43 12 (27.9)

Histopathology
Adenocarcinoma 27 11 (40.7)
Squamous cell (Epidermoid) 34 5 (14.7)
Not otherwise specified (NOS) 12 5 (41.6)